Literature DB >> 8267997

University of Wisconsin solution and human saphenous vein graft preservation: preliminary anatomic report.

E Santoli1, D Di Mattia, R Boldorini, A Mingoli, A Tosoni, C Santoli.   

Abstract

Endothelial damage of human saphenous vein (HSV) during the preparation for bypass grafting could affect graft patency. Improving the preservation of HSV could provide a longer and better patency of coronary artery bypass grafts. An electron microscopic comparative analysis of the effects of three different preservatives on HSV morphology was carried on in order to determine the best method to prevent or minimize possible endothelial damage. Distal segments of HSVs were harvested from 15 patients with a "no-touch" technique. Each segment was divided into seven specimens after a low pressure distension with saline solution. The first of them was fixed immediately after harvesting with 2.5% glutaraldehyde solution, for basal evaluation. Three were fixed after 30 min and three after 5 h preservation at 4 degrees C in a) autologous, oxygenated, and heparinized blood (AOHB), b) heparinized saline solution with papaverine (HSSP) and c) University of Wisconsin solution (UWS). The specimens preserved in AOHB showed marked endothelial cell detachment and endothelial cell loss after both preservation times (30 min and 5 h). The specimens preserved in HSSP for 30 min showed no alteration in endothelium in 12 cases, while a partial endothelial detachment with intracellular edema was present in the last 3 cases; all 5 h specimens showed only a few remnants of endothelial cells. The specimens preserved in UWS for 30 min showed a morphology comparable to specimens preserved in the saline solution for the same time; in the 5 h specimens a well preserved endothelium was found in 11 cases and partial endothelial detachment and subendothelial edema in the other 4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267997     DOI: 10.1016/1010-7940(93)90055-g

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Storage of saphenous vein grafts prior to coronary artery bypass grafting: is autologous whole blood more effective than saline in preserving graft function?

Authors:  Maria Tsakok; Sarah Montgomery-Taylor; Teresa Tsakok
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-29

2.  Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft.

Authors:  Eric S Wise; Kyle M Hocking; Susan Eagle; Tarek Absi; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Surgery       Date:  2015-05-21       Impact factor: 3.982

3.  Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.

Authors:  Ralf E Harskamp; John H Alexander; Phillip J Schulte; Colleen M Brophy; Michael J Mack; Eric D Peterson; Judson B Williams; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; Robert A Harrington; T Bruce Ferguson; Renato D Lopes
Journal:  JAMA Surg       Date:  2014-08       Impact factor: 14.766

Review 4.  Saphenous vein grafts in contemporary coronary artery bypass graft surgery.

Authors:  Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2019-08-27       Impact factor: 32.419

5.  Saphenous vein endothelial cell viability: a comparative study of endoscopic and open saphenectomy for coronary artery bypass grafting.

Authors:  S J Alrawi; R Raju; G Alshkaki; A J Acinapura; J N Cunningham
Journal:  JSLS       Date:  2001 Jan-Mar       Impact factor: 2.172

6.  Nafamostat mesilate: can it be used as a conduit preserving agent in coronary artery bypass surgery?

Authors:  Yoo Sang Yoon; Hyunkong Oh; Yonghwan Kim; Seung Pyung Lim; Cuk-Seong Kim; Min-Woong Kang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.